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Background
The relation between body weight and mortality among persons with type 2 
 diabetes remains unresolved, with some studies suggesting decreased mortality 
among overweight or obese persons as compared with normal-weight persons 
(an “obesity paradox”).
Methods
We studied participants with incident diabetes from the Nurses’ Health Study 
(8970 participants) and Health Professionals Follow-up Study (2457 participants) 
who were free of cardiovascular disease and cancer at the time of a diagnosis of 
diabetes. Body weight shortly before diagnosis and height were used to calculate 
the body-mass index (BMI, the weight in kilograms divided by the square of the 
height in meters). Multivariable Cox models were used to estimate the hazard ratios 
and 95% confidence intervals for mortality across BMI categories.
Results
There were 3083 deaths during a mean period of 15.8 years of follow-up. A J-shaped 
association was observed across BMI categories (18.5 to 22.4, 22.5 to 24.9 [reference], 
25.0 to 27.4, 27.5 to 29.9, 30.0 to 34.9, and ≥35.0) for all-cause mortality (hazard 
ratio, 1.29 [95% confidence interval {CI}, 1.05 to 1.59]; 1.00; 1.12 [95% CI, 0.98 to 
1.29]; 1.09 [95% CI, 0.94 to 1.26]; 1.24 [95% CI, 1.08 to 1.42]; and 1.33 [95% CI, 
1.14 to 1.55], respectively). This relationship was linear among participants who had 
never smoked (hazard ratios across BMI categories: 1.12, 1.00, 1.16, 1.21, 1.36, 
and 1.56, respectively) but was nonlinear among participants who had ever smoked 
(hazard ratios across BMI categories: 1.32, 1.00, 1.09, 1.04, 1.14, and 1.21) (P = 0.04 
for interaction). A direct linear trend was observed among participants younger 
than 65 years of age at the time of a diabetes diagnosis but not among those 
65 years of age or older at the time of diagnosis (P<0.001 for interaction).
Conclusions
We observed a J-shaped association between BMI and mortality among all partici-
pants and among those who had ever smoked and a direct linear relationship 
among those who had never smoked. We found no evidence of lower mortality 
among patients with diabetes who were overweight or obese at diagnosis, as com-
pared with their normal-weight counterparts, or of an obesity paradox. (Funded by 
the National Institutes of Health and the American Diabetes Association.)
The New England Journal of Medicine 
Downloaded from nejm.org on May 2, 2016. For personal use only. No other uses without permission. 
 Copyright © 2014 Massachusetts Medical Society. All rights reserved. 
T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
n engl j med 370;3 nejm.org january 16, 2014234
Excess adiposity is a well-established risk factor for premature death in the general population, including death due 
to cardiovascular disease or cancer.1-4 However, 
a so-called obesity paradox (i.e., an association 
between obesity, as compared with normal 
weight, and reduced mortality) has been reported 
among patients with heart failure, end-stage renal 
disease, or hypertension, and, recently, among 
those with type 2 diabetes.5-12 Most of these 
studies, however, have been limited by small sam-
ples and suboptimal control for smoking status 
and preexisting chronic conditions.
Smoking is a concern in analyses of body 
weight and mortality because it is associated 
with decreased body weight but an increased 
risk of death.13 Statistical adjustment for smok-
ing status (e.g., ever smoked vs. never smoked) 
is often insufficient to control for varying de-
grees of smoking duration and intensity. Thus, 
stratification according to smoking status can 
be an important way to examine the association 
between body weight and the risk of death; in 
addition, the subgroup analysis among persons 
who have never smoked can reduce residual bias 
related to smoking.3,4,13-15 An additional concern 
is reverse causation, whereby underlying chronic 
disease or frailty both causes weight loss and ele-
vates the risk of death. Exclusion of persons with 
known illnesses at baseline and censoring of data 
for patients who died early in the follow-up period 
are routinely performed to reduce this bias.16
To address the limitations of previous analy-
ses, we conducted a detailed analysis of the as-
sociation between body-mass index (BMI) and 
the risk of death among participants with inci-
dent diabetes from two large prospective cohort 
studies, the Nurses’ Health Study (NHS) and the 
Health Professionals Follow-up Study (HPFS).
Me thods
Study Population
The NHS was initiated in 1976 with the enroll-
ment of 121,700 female nurses 30 to 55 years of age. 
The HPFS began in 1986, enrolling 51,529 male 
health professionals between 40 and 75 years of 
age. Questionnaires are administered biennially to 
update medical, lifestyle, and other health-related 
information.17,18 Cumulative follow-up exceeds 
90% of potential person-time for both cohorts.
Our analyses included women and men report-
ing incident diabetes between baseline (1976 for 
the NHS and 1986 for the HPFS) and January 1, 
2010 (Fig. S1 in the Supplementary Appendix, avail-
able with the full text of this article at NEJM.org). 
We excluded participants reporting a history of dia-
betes at baseline or reporting cardiovascular dis-
ease (stroke, coronary heart disease, or coronary-
artery bypass graft surgery) or cancer before a 
diabetes diagnosis. Participants were excluded if 
they were underweight (BMI [the weight in kilo-
grams divided by the square of height in meters] 
<18.5, because of limited statistical power for this 
group), had received a diagnosis of diabetes before 
35 years of age (probably type 1 diabetes), or did 
not report body weight on the relevant question-
naire. The study protocol was approved by the in-
stitutional review boards of Brigham and Women’s 
Hospital and the Harvard School of Public Health, 
with participants’ consent implied by the return of 
the questionnaires. The first, second, and last au-
thors take complete responsibility for the integrity 
of the data and the accuracy of the data analysis.
Assessment of Type 2 Diabetes
Participants reporting a physician’s diagnosis of 
diabetes on the biennial questionnaire were 
mailed a supplemental questionnaire. Confirmed 
cases were defined according to the National 
Diabetes Data Group classification,19 updated in 
June 1998 to adopt a new threshold for a fasting 
plasma glucose level of at least 126 mg per deci-
liter (7.0 mmol per liter).20 Validation studies with 
the use of medical records for 62 NHS partici-
pants21 and 59 HPFS participants22 showed very 
high accuracy of our classification (98% and 97%, 
respectively).
Assessment of Body-Mass Index
Body weight was updated every 2 years by ques-
tionnaire. Weight at diagnosis was estimated 
from the most recent questionnaire before the 
diagnosis (mean time from questionnaire to di-
agnosis, 11 months). Self-reported weight was pre-
viously validated in a subgroup of 140 NHS par-
ticipants and 123 HPFS participants (<1% of all 
participants) living in the Boston area, on the basis 
of the correlation between technician-measured 
and self-reported weight (Spearman correlation 
coefficient, 0.97 for both NHS and HPFS partici-
pants; mean difference [self-reported weight minus 
measured weight], −1.50 kg for NHS participants 
and −1.06 kg for HPFS participants).23 A sensitivity 
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analysis assessed the potential effect of error in 
self-reported weight and height with the use of 
the sex-specific calibration equations proposed 
by Berrington de Gonzalez et al.3 from the U.S. 
National Health and Nutrition Evaluation Survey 
sample (BMImeasured = 0.63 + [1.01 × BMIself-reported] + 
[0.0006 × age in years] for women and 0.29 + 
[0.98 × BMIself-reported] + [0.012 × age in years] for men).
Ascertainment of Deaths
The primary outcome was death from any cause 
through January 1, 2012. Most deaths (>98%) were 
identified from reports by the next of kin or postal 
authorities or from searches of the National Death 
Index.24,25 The cause of death was determined by 
physician review of medical records and death 
certificates. The diagnostic codes of the Interna-
tional Classification of Diseases, 8th Revision (ICD-8), 
were used to classify deaths as due to cardio-
vascular disease (ICD-8 codes 390 through 459 
and 795), cancer (ICD-8 codes 140 through 207), 
or other causes.
Assessment of Covariables
Detailed information on cigarette smoking, physi-
cal activity, menopausal status (for NHS partici-
pants only), and several lifestyle factors and health 
outcomes were updated every 2 years. Marital 
status and status with respect to a family history 
of diabetes were assessed periodically. Dietary 
information was collected from validated food-
frequency questionnaires approximately every 
4 years. Diet quality was assessed with the use 
of the 2010 Alternate Healthy Eating Index 
(with scores ranging from 2.5 to 87.5 and higher 
scores indicating a healthier diet).26 The covari-
ables were derived from the most recent ques-
tionnaire before a diabetes diagnosis.
Statistical Analysis
Hazard ratios and 95% confidence intervals were 
estimated from Cox proportional-hazards models, 
with number of months since a diabetes diagno-
sis as the time scale. Person-time was calculated 
from the date of a diabetes diagnosis until death 
or the end of follow-up (January 1, 2012). BMI 
categories were defined as follows: 18.5 to 22.4, 
22.5 to 24.9 (reference), 25.0 to 27.4, 27.5 to 29.9, 
30.0 to 34.9, and 35.0 or higher. Multivariable 
models were adjusted for race or ethnic group 
(white, black, Asian American, Hispanic, or other), 
smoking status (never smoked; previously smoked; 
currently smokes 1 to 14, 15 to 24, or ≥25 cigarettes 
per day; or not reported), alcohol consumption 
(women: 0, 0.1 to 4.9, 5.0 to 14.9, or ≥15.0 g per day; 
men: 0, 0.1 to 4.9, 5.0 to 29.9, or ≥30.0 g per day), 
physical activity (<3.0, 3.0 to 8.9, 9.0 to 17.9, 18.0 to 
26.9, or ≥27.0 hours of metabolic-equivalent tasks 
per week), marital status (married or unmarried), 
diet quality (in quintiles of Alternate Healthy Eat-
ing Index scores), family history of diabetes (yes 
or no), and menopausal status (for NHS partici-
pants only). The P values for linear trend were 
computed by modeling BMI as a continuous var-
iable. Nonlinear trends were assessed with like-
lihood-ratio tests of restricted cubic splines.27 
A P value of less than 0.05 was considered to in-
dicate a significant linear or nonlinear trend. 
The hazard-ratio estimates for the two cohorts 
were combined with the use of fixed-effect meta-
analyses with inverse-variance weighting.
We repeated our analyses with stratification ac-
cording to baseline smoking status and with early 
deaths (<4 years after diagnosis) excluded. Effect 
modification by smoking status (never smoked 
vs. ever smoked) and age at diagnosis (<65 years 
vs. ≥65 years) was estimated from the multiplica-
tive interaction term between continuous BMI 
and the effect modifier added to the main effects 
model. The proportional-hazards assumption was 
evaluated with a likelihood-ratio test comparing 
the model with and without an interaction term 
between time period and BMI category. Data were 
analyzed with the use of SAS software, version 9.2 
(SAS Institute), at a two-tailed alpha level of 0.05.
R esult s
Study Participants
For the 11,427 participants included in our analysis, 
the mean age at diabetes diagnosis was 62 years 
(range, 35 to 86) among the 8970 NHS partici-
pants and 64 years (range, 41 to 91) among the 
2457 HPFS participants. Baseline characteristics 
are presented in Table 1, stratified according to 
BMI categories. A higher BMI at diagnosis was 
inversely associated with age at diagnosis, physi-
cal activity, and Alternate Healthy Eating Index 
score. The lowest BMI category (18.5 to 22.4) had 
the highest prevalence of current smokers, and 
normal-weight participants (BMI, 18.5 to 24.9) 
were more likely to have lost weight before diag-
nosis than overweight participants (BMI, 25.0 to 
29.9) and obese participants (BMI, ≥30).
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All-Cause Mortality
A total of 3083 deaths from all causes were ob-
served over a mean follow-up of 15.8 years, with 
a maximum follow-up of 36 years among women 
(mean, 16.2 years; 16.1 deaths per 1000 person-
years) and 26 years among men (mean, 14.5 years; 
21.8 deaths per 1000 person-years). The mean 
(±SD) age at death was 74.6±7.8 years for women 
and 78.7±8.7 years for men. In general, crude 
rates of death were higher among participants 
who had ever smoked than among those who had 
never smoked, across BMI categories (Table 2).
A J-shaped association between BMI and all-
cause mortality was observed among all the par-
ticipants (Table 2) (P<0.001 for nonlinearity among 
NHS participants; P = 0.59 among HPFS partici-
pants). As compared with participants with a BMI 
of 22.5 to 24.9, those in the lowest BMI category, 
18.5 to 22.4, had a significantly elevated all-cause 
mortality (hazard ratio, 1.29; 95% confidence 
interval [CI], 1.05 to 1.59), as did those in the 
highest BMI categories (BMI of 30.0 to 34.9: haz-
ard ratio, 1.24; 95% CI, 1.08 to 1.42; BMI ≥35.0: 
hazard ratio, 1.33; 95% CI, 1.14 to 1.55).
Results indicated significant effect modifi-
cation according to smoking status (Table 2) 
(P = 0.04 for interaction), with divergent trends in 
the risk of death across BMI strata for  participants 
who had ever smoked as compared with those 
who had never smoked. A sig nificant linear trend 
was seen among participants who had never 
smoked (P<0.001), with no evidence of a nonlin-
Table 1. Baseline Characteristics of the Study Participants, According to Body-Mass Index (BMI) Categories.*
Characteristic BMI Category
18.5–22.4 22.5–24.9 25.0–27.4 27.5–29.9 30.0–34.9 ≥35.0
NHS cohort: women
No. of participants 362 737 1465 1452 2740 2214
Age at the questionnaire return before diabetes  
diagnosis (yr)
63.2±11.0 62.8±10.2 62.7±9.2 62.4±8.8 60.7±8.6 58.3±8.4
Age at diabetes diagnosis (yr) 64.4±11.1 63.9±10.2 63.9±9.2 63.6±8.8 61.9±8.6 59.5±8.4
BMI 21.3±1.0 23.9±0.7 26.5±0.8 28.9±0.6 32.3±1.4 39.4±3.2
Physical activity (MET­hr/wk) 16.9±20.7 16.5±27.6 15.6±24.1 13.7±18.7 12.2±17.0 8.7±13.3
Alcohol intake (g/day) 5.7±10.7 5.3±9.5 4.0±8.5 3.6±7.9 2.8±6.7 2.1±6.5
Alternate Healthy Eating Index score† 53.0±11.7 52.9±10.9 51.9±10.7 51.8±11.0 50.4±10.6 48.9±10.5
Change in BMI during 2 yr before diabetes diagnosis −0.1±2.6 0.4±3.1 0.8±3.7 1.4±4.4 1.7±5.4 2.9±7.1
Reduction in BMI of >1 unit during 2 yr before diabetes 
diagnosis (%)
21.9 18.9 19.8 16.5 18.2 16.7
White race (%)‡ 93.9 94.6 95.2 94.8 96.0 96.3
One or more symptoms of diabetes at diagnosis (%) 35.4 34.7 37.9 40.6 39.6 44.2
Insulin use in first yr after diagnosis (%) 7.7 8.1 8.1 6.3 7.4 8.4
Postmenopausal (%) 77.9 78.0 78.8 79.7 76.2 69.3
Smoking status (%)
Never smoked 43.4 43.8 45.7 43.9 44.6 45.5
Former smoker 34.3 38.3 37.8 41.0 41.6 43.2
Current smoker
<15 cigarettes/day 14.4 13.6 12.8 10.6 9.9 8.0
≥15 cigarettes/day 7.5 4.3 3.3 4.5 3.7 3.0
Unknown 0.6 0.0 0.4 0.1 0.2 0.3
Married (%) 67.7 71.2 69.8 69.8 70.9 70.0
Family history of diabetes (%) 44.8 49.3 48.2 47.9 48.4 46.8
Hypercholesterolemia (%) 33.2 37.7 41.3 37.6 35.3 30.2
High blood pressure (%) 35.4 38.9 42.8 45.8 50.0 49.0
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ear trend (P = 0.41 for NHS participants; P = 0.22 
for HPFS participants). Among participants who 
had ever smoked, however, there was a nonlinear 
J-shaped trend in the combined cohort of men 
and women and in the cohort of women (P<0.001 
for NHS participants) but not in the cohort of 
men (P = 0.72 for HPFS participants).
Significant effect modification according to 
age at diagnosis was observed (P<0.001 for inter-
action) (Table S1 in the Supplementary Appendix). 
Among adults younger than 65 years of age at 
diagnosis, there was a direct linear relationship 
between BMI and all-cause mortality (P<0.001 
for linear trend among total participants, those 
who had never smoked, and those who had ever 
smoked). In contrast, a direct linear trend among 
participants 65 years of age or older at diagnosis 
was observed only among those who had never 
smoked (P = 0.04), and among participants who 
had ever smoked, a significantly increased risk 
of death was observed only in the lowest BMI 
category (hazard ratio, 1.89; 95% CI, 1.32 to 2.71).
The results of the analyses that assessed re-
sidual confounding by smoking status and re-
verse causation are depicted in Figures 1A 
through 1F. Exclusion of participants who died in 
Table 1. (Continued.)
Characteristic BMI Category
18.5–22.4 22.5–24.9 25.0–27.4 27.5–29.9 30.0–34.9 ≥35.0
HPFS cohort: men
No. of participants 64 337 630 558 620 248
Age at the questionnaire return before diabetes  
diagnosis (yr)
68.0±9.3 66.5±9.2 64.1±8.5 63.5±8.3 61.1±8.0 58.6±7.8
Age at diabetes diagnosis (yr) 69.2±9.3 67.6±9.2 65.2±8.5 64.6±8.2 62.3±8.1 59.7±7.7
BMI 21.4±1.0 23.9±0.6 26.2±0.8 28.7±0.7 32.0±1.4 38.5±3.6
Physical activity (MET­hours/wk) 34.0±39.0 32.0±33.4 28.2±31.4 27.0±35.8 24.9±36.0 17.8±25.1
Alcohol intake (g/day) 10.1±14.8 8.8±12.3 10.1±14.1 10.8±16.8 10.0±15.1 7.2±12.1
Alternate Healthy Eating Index score† 53.7±12.7 55.6±12.2 53.8±11.7 52.8±11.3 51.9±10.9 51.0±10.8
Change in BMI during 2 yr before diabetes diagnosis −0.4±1.3 −0.3±1.0 −0.1±1.3 0.1±1.3 0.3±1.9 0.8±2.2
Reduction in BMI of >1 unit in 2 yr before diabetes 
diagnosis (%)
23.5 19.2 16.9 14.9 17.1 15.5
White race (%)‡ 90.6 89.0 93.2 94.6 94.5 95.2
One or more symptoms of diabetes at diagnosis (%) 43.8 40.4 45.9 49.1 51.9 59.3
Insulin use in first yr after diagnosis (%) 4.7 1.2 2.4 2.3 2.1 2.4
Smoking status (%)
Never smoked 40.6 40.7 37.9 38.4 42.3 45.6
Former smoker 40.6 47.5 51.3 52.0 47.6 46.8
Current smoker
<15 cigarettes/day 12.5 8.0 5.4 3.6 5.2 1.6
≥15 cigarettes/day 3.1 1.5 2.2 2.0 2.3 2.4
Unknown 3.1 2.4 3.2 4.1 2.7 3.6
Married (%) 84.4 83.7 81.3 80.5 81.6 77.0
Family history of diabetes (%) 40.6 50.5 50.8 48.2 49.8 46.0
Hypercholesterolemia (%) 60.9 48.4 52.2 50.0 50.2 48.4
High blood pressure (%) 46.9 43.0 48.4 57.7 60.7 68.2
* The study included participants with incident type 2 diabetes from the Nurses’ Health Study (NHS) and the Health Professionals Follow­up 
Study (HPFS). Plus–minus values are means ±SD. MET denotes metabolic­equivalent tasks.
† Scores on the Alternate Healthy Eating Index range from 2.5 to 87.5, with higher scores indicating a healthier diet.
‡ Race was self­reported.
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the first 4 years of follow-up (a total of 227 par-
ticipants: 78 who had never smoked and 149 who 
had ever smoked) (Fig. 1B, 1D, and 1F, respectively) 
resulted in a monotonic positive association be-
tween BMI and death among participants who 
had never smoked, and the results did not differ 
substantially from those of the primary analysis. 
Exclusion of participants with weight loss of more 
than 1 BMI unit before a diabetes diagnosis, 
adjustment for baseline hypertension or hyper-
cholesterolemia, and adjustment for year of dia-
betes diagnosis produced similar results (data not 
shown). The tests for the proportional-hazards 
assumption did not indicate a violation in either 
cohort. Age-adjusted survival curves are depicted 
in Figures S2A through S2D in the Supplemen-
tary Appendix.
Using the traditional cutoff points for the BMI 
categories of normal weight, overweight, and 
obesity (Table S2 in the Supplementary Appendix) 
and correcting errors in self-reported weight and 
height (Table S3 in the Supplementary Appendix) 
did not significantly change the results.
Cause-Specific Mortality
We assessed the relationship between BMI just be-
fore a diabetes diagnosis and deaths due to cardio-
vascular disease (941 deaths), cancer (784 deaths), 
and other causes (e.g., respiratory diseases, re-
nal disease, suicide, and accidents; 1358 deaths) 
(Fig. 2A, 2B, and 2C; and Table S4 in the Supple-
mentary Appendix). There was a significant di-
rect linear relationship between BMI and car-
diovascular mortality among all participants 
(P<0.001 for linear trend) and among those who 
had never smoked (P = 0.004), but the relation-
ship appeared to be attenuated among those who 
had ever smoked (P = 0.02). In the lowest BMI 
category (18.5 to 22.4), a significant increase in 
cancer mortality was seen among all participants 
(hazard ratio, 1.51; 95% CI, 1.00 to 2.28) and 
among those who had ever smoked (hazard ratio, 
1.87; 95% CI, 1.15 to 3.04) but not among those 
who had never smoked (hazard ratio, 0.83; 95% 
CI, 0.34 to 2.05). The relationship between BMI 
and mortality from other causes appeared to be 
J-shaped for all participants.
Discussion
Our analyses of data from two large, long-term, 
prospective cohort studies indicate a J-shaped as-N
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sociation between BMI immediately before a di-
agnosis of type 2 diabetes and all-cause mortality. 
This relationship was linear among participants 
who had never smoked but was nonlinear among 
those who had ever smoked. We did not observe 
a benefit of excess adiposity with regard to the 
risk of death; thus, our findings support the cur-
rent recommendation that patients with diabetes 
achieve or maintain a normal weight.28
Although our findings are largely consistent 
with the results of previous analyses in the 
general population,1-4 they contradict the re-
sults of several studies of BMI and mortality 
among participants with diabetes. Prior studies 
largely suggest inverse,10 J- or U-shaped,11,29,30 
or f lat or null associations9,31; however, nota-
ble limitations include a short follow-up dura-
tion,9,11,30 a small number of deaths,10,29,31,32 and 
a lack of analyses assessing biases from smok-
ing or undiagnosed chronic diseases.9-11,29-32 
The majority of these studies involved patients 
who already had diabetes, with BMI assessed 
up to several decades after the diagnosis; these 
factors substantially increase susceptibility to 
reverse-causation bias.9,29-32
Recently, Carnethon et al.10 analyzed pooled 
data from five large U.S. cohorts and concluded 
that adults who were of normal weight at the 
time of a diabetes diagnosis had a risk of death 
that was twice as high as that among their over-
weight or obese counterparts (hazard ratio, 2.01; 
95% CI, 1.44 to 2.81); however, several of the 
limitations outlined above apply to this study. 
Relatively low statistical power (449 total deaths) 
limited their BMI classification to two broad and 
heterogeneous exposure groups (participants with 
a BMI of 18.5 to 24.9 and those with a BMI ≥25.0). 
Subgroup analyses were also underpowered, such 
that conclusions could not be drawn. In addition, 
BMI was measured after the diabetes diagnosis 
for many participants, allowing additional bias 
from the initiation of diabetes treatment or the 
progression of other underlying illnesses.10
The attenuated relationship between BMI and 
mortality among smokers has frequently been 
observed in the general population.3,4,14,15 It is 
unclear whether this effect modification repre-
sents biologic differences between smokers and 
nonsmokers or is largely due to bias.13 Additional 
studies are needed to answer this question.
In our study, effect modification according to 
age at diagnosis indicated a direct linear trend 
among participants younger than 65 years of age 
but a null or weakened linear association among 
participants 65 years of age or older. These 
findings, which are consistent with the results 
of previous studies involving participants with 
type 2 diabetes32 and the general popula-
tion,1,33 may reflect well-known limitations in 
analyses of mortality among older persons, in-
cluding an increased prevalence of coexisting 
chronic diseases, which increases the potential 
for reverse-causation bias; an increased preva-
lence of competing risk factors, which reduces 
the proportional effect of a single factor; and 
decreased validity of BMI as a measure of 
 adiposity owing to age-related declines in 
 muscle mass and wasting.34 It has also been 
suggested that excess adiposity may confer a 
metabolic advantage and improved survival 
among the elderly. Therefore, caution should be 
taken in interpreting the results among the 
older participants.
Our findings with respect to the relationship 
between BMI and mortality due to specific 
causes are consistent with those of prior stud-
ies conducted in the general population.2-4,14,15 
Among participants who had never smoked, 
the relationship of BMI to both cardiovascular 
mortality and cancer mortality appeared to be 
monotonic and linear. No significant associa-
tion was observed between any BMI category 
and the risk of death from cardiovascular dis-
ease among participants who had ever smoked; 
however, participants in the lowest BMI catego-
ry who had ever smoked had a significantly 
elevated risk of death from cancer.
Proposed biologic mechanisms of the al-
leged obesity paradox include an increased ge-
netic influence and more severe diabetes among 
normal-weight persons with diabetes or the 
effect of a “metabolically obese normal weight” 
phenotype.35,36 However, normal-weight par-
ticipants in our cohort were no more likely to 
report diabetes symptoms or coexisting chronic 
diseases or to require insulin than were over-
weight or obese participants. In contrast, nor-
mal-weight participants were more likely to be 
smokers and to have lost weight before a diag-
nosis of diabetes. Comparisons with this het-
erogeneous normal-weight group may therefore 
underestimate the risk of death among the 
overweight and obese.
Strengths of our study include the large 
sample (3083 deaths among 11,427 adults with 
incident diabetes), permitting detailed exami-
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Figure 1. Hazard Ratios for All-Cause Mortality among Participants with Incident Type 2 Diabetes, According to 
Body-Mass Index (BMI) Shortly before Diagnosis of Type 2 Diabetes.
The results from the two cohorts (Nurses’ Health Study [NHS] and Health Professionals Follow­up Study) were 
combined with the use of a fixed­effect meta­analysis. Panel A shows the results for the total study population 
(3083 deaths; 179,081 person­years). Panel B shows the results of the analysis that excluded deaths occurring in the first 
4 years of follow­up (2856 deaths; 177,906 person­years). Panel C shows the results for participants who had never 
smoked (1167 deaths; 79,946 person­years). Panel D shows the results for participants who had never smoked, with the 
exclusion of deaths occurring in the first 4 years of follow­up (1089 deaths; 79,546 person­years). Panel E shows the re­
sults for participants who had ever smoked (1892 deaths; 97,762 person­years). Panel F shows the results for participants 
who had ever smoked, with the exclusion of deaths occurring in the first 4 years of follow­up (1743 deaths; 96,999 person­
years). All estimates have been adjusted for age, race, marital status, menopausal status (for the NHS cohort only), 
presence or absence of a family history of diabetes, smoking status (in Panels A, B, E, and F), alcohol intake,  Alternate 
Healthy Eating Index score, and physical activity. A total of 20 women (7 deaths) and 79 men (17 deaths) with missing 
data on smoking status were excluded from the stratified analyses. The bars represent 95% confidence intervals.
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nation across multiple BMI categories and key 
analyses to address potential biases. Prospec-
tively measured body weight, documented just 
before or at the time of a diabetes diagnosis, 
prevents misclassification from weight change 
due to early pharmacologic treatments or life-
style changes shortly after diagnosis. Enroll-
ment of health professionals has proved benefi-
cial with respect to the reliability and validity 
of self-reported health-related exposures and 
outcomes, and it reduces confounding by edu-
cational and socioeconomic factors.
Limitations of the study include the reliance 
on self-reported weight measures, although er-
roneous reporting was shown to be very mini-
mal in validation studies, and corrections of 
errors in BMI measurement produced similar 
findings. Information on weight was obtained 
an average of 11 months before diagnosis as a 
proxy for the weight at diagnosis, but this is 
unlikely to have resulted in appreciable error. 
Finally, the relative homogeneity of the NHS 
and HPFS cohorts may limit the generalizabil-
ity of our findings to other racial and ethnic 
groups.
In conclusion, our results indicate a J-shaped 
relationship between BMI at the time of a dia-
betes diagnosis and the risk of death from all 
causes, with the lowest risk observed among 
normal-weight participants with a BMI of 22.5 
to 24.9. Among participants who had never 
smoked, there was a direct linear relationship 
between BMI and mortality, whereas a nonlin-
ear relationship was observed among those 
who had ever smoked. There was no evidence 
of a protective effect of overweight or obesity 
on mortality. In addition, given the relationship 
of overweight and obesity to other critical pub-
lic health end points (e.g., cardiovascular dis-
ease and cancer), the maintenance of a healthy 
body weight should remain the cornerstone of 
diabetes management, irrespective of smoking 
status. Further evidence is needed to corrobo-
rate our findings in other populations.
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Figure 2 (facing page). Hazard Ratios for Cause-Specific 
Mortality among Participants with Incident Type 2 
 Diabetes,  According to BMI Shortly before Diagnosis  
of Type 2 Diabetes.
The results from the two cohorts (NHS and Health Pro­
fessionals Follow­up Study) were combined with the use 
of a fixed­effect meta­analysis. The numbers of person­
years were 179,081 for all participants, 79,546 for those 
who had never smoked, and 97,762 for those who had 
ever smoked. Panel A shows cardiovascular mortality in 
the total study population (941 deaths), among partici­
pants who had never smoked (340 deaths), and among 
those who had ever smoked (592 deaths). Panel B shows 
cancer mortality in the total study population (784 deaths), 
among participants who had never smoked (266 deaths), 
and among those who had ever smoked (514 deaths). 
Panel G shows mortality from other causes in the total 
study population (1358 deaths), among participants 
who had never smoked (561 deaths), and among those 
who had ever smoked (786 deaths). All estimates have 
been adjusted for age, race, marital status, menopausal 
status (for the NHS cohort only), presence or absence of 
a family history of diabetes, smoking status (among all 
participants and those who had ever smoked), alcohol 
 intake, and Alternate Healthy Eating Index score. A total 
of 20 women and 79 men with missing data on smoking 
status were excluded from the stratified analyses (24 total 
deaths, including 9 from cardiovascular causes, 4 from 
cancer, and 11 from other causes). The bars represent 
95% confidence intervals.
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